Emory University is treating two US patients suffering from ebola, with help from a Boston spin-out.

Led by Spring Mountain Capital, the round also includes Yale University.

Allied Minds and Bristol-Myers Squibb are joining forces to foster biopharmaceutical research at US universities.

Novo-backed Tobira, which is developing treatments for liver disease and HIV among other ailments, cited market conditions as it withdrew from a $60m IPO.

The IdInvest-backed company, which is developing a treatment for tinnitus, has gone public in an underpriced IPO.

Google Ventures-backed healthcare-on-demand service Doctor on Demand has raised $21m in series A funding to expand its client offerings.

Health startup Cerora closed the round for the second time.